Inability of Radioiodine Remnant Ablation to Improve Postoperative Outcome in Adult Patients with Low-Risk Papillary Thyroid Carcinoma
Open Access
- 17 March 2021
- journal article
- research article
- Published by Elsevier BV in Mayo Clinic Proceedings
- Vol. 96 (7), 1727-1745
- https://doi.org/10.1016/j.mayocp.2021.02.009
Abstract
No abstract availableKeywords
Funding Information
- Mayo Foundation
This publication has 53 references indexed in Scilit:
- Generalizability of Epidemiological Findings and Public Health Decisions: An Illustration From the Rochester Epidemiology ProjectMayo Clinic Proceedings, 2012
- The Effectiveness of Radioactive Iodine for Treatment of Low-Risk Thyroid Cancer: A Systematic Analysis of the Peer-Reviewed Literature from 1966 to April 2008Thyroid®, 2010
- Perspective: The Case Against Radioiodine Remnant Ablation in Patients with Well-Differentiated Thyroid CarcinomaJournal of Nuclear Medicine, 2008
- Staging Systems for Papillary Thyroid CarcinomaAnnals of Surgery, 2007
- European consensus for the management of patients with differentiated thyroid carcinoma of the follicular epitheliumActa Endocrinologica, 2006
- Management Guidelines for Patients with Thyroid Nodules and Differentiated Thyroid Cancer: The American Thyroid Association Guidelines TaskforceThyroid®, 2006
- Application of Staging Systems for Differentiated Thyroid Carcinoma in an Endemic Goiter Region With Iodine SubstitutionAnnals of Surgery, 2003
- Presidential address: Beyond risk groups—A new look at differentiated thyroid cancerSurgery, 1998
- The history of the use of radioactive iodineSeminars in Nuclear Medicine, 1979
- PAPILLARY THYROID CARCINOMAMedicine, 1977